Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Clinical trial NCT07614061 · RECRUITING

Trial details

NCT number: NCT07614061
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Biliary Tract Neoplasms Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, Perihilar Gallbladder Cancer

Start date: 2026-05-01
Primary completion: 2028-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.